CCM

Camber Capital Management Portfolio holdings

AUM $718M
This Quarter Return
+30.56%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.93B
AUM Growth
+$1.93B
Cap. Flow
-$180M
Cap. Flow %
-9.3%
Top 10 Hldgs %
57.59%
Holding
37
New
5
Increased
6
Reduced
6
Closed
9

Top Buys

1
GILD icon
Gilead Sciences
GILD
$97.5M
2
GBT
Global Blood Therapeutics, Inc.
GBT
$58M
3
VTR icon
Ventas
VTR
$43.3M
4
MD icon
Pediatrix Medical
MD
$22M
5
TEVA icon
Teva Pharmaceuticals
TEVA
$19.6M

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
$76.1M
2
THOR
Synthorx, Inc. Common Stock
THOR
$60.3M
3
ABBV icon
AbbVie
ABBV
$37.9M
4
DVA icon
DaVita
DVA
$37.5M
5
ZYME icon
Zymeworks
ZYME
$37.2M

Sector Composition

1 Healthcare 95%
2 Real Estate 2.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TBIO
26
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$12.2M 0.62%
1,500,000
– –
TECX
27
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$12.1M 0.61%
600,000
+100,000
+20% +$2.01M
STRO icon
28
Sutro Biopharma
STRO
$85.6M
$6.6M 0.34%
600,000
– –
UTHR icon
29
United Therapeutics
UTHR
$17.7B
– –
-400,000
Closed -$31.9M
SGRY icon
30
Surgery Partners
SGRY
$2.89B
– –
-160,084
Closed -$1.18M
NVO icon
31
Novo Nordisk
NVO
$252B
– –
-700,000
Closed -$36.2M
GSK icon
32
GSK
GSK
$79.3B
– –
-500,000
Closed -$21.3M
CYCN icon
33
Cyclerion Therapeutics
CYCN
$7.75M
– –
-2,227,052
Closed -$27M
BMY icon
34
Bristol-Myers Squibb
BMY
$96.7B
– –
-1,500,000
Closed -$76.1M
ABBV icon
35
AbbVie
ABBV
$374B
– –
-500,000
Closed -$37.9M
WMGI
36
DELISTED
Wright Medical Group Inc
WMGI
– –
-750,000
Closed -$15.5M
ZYME icon
37
Zymeworks
ZYME
$1.07B
– –
-1,500,000
Closed -$37.2M
1
2